所有图片(1)
About This Item
线性分子式:
C2H5OCH2CH2OCH2CH2OH
CAS号:
分子量:
134.17
Beilstein:
1736441
EC 号:
MDL编号:
UNSPSC代码:
12352112
PubChem化学物质编号:
等级:
reagent grade
方案:
99%
沸点:
202 °C (lit.)
蒸汽压:
0.12 mmHg ( 20 °C)
推荐产品
等级
reagent grade
蒸汽密度
4.63 (vs air)
蒸汽压
0.12 mmHg ( 20 °C)
产品线
Vetec™
方案
99%
表单
liquid
expl. lim.
1.2 %, 135 °F
23.5 %, 182 °F
杂质
≤0.10% water
water
折射率
n20/D 1.427 (lit.)
沸点
202 °C (lit.)
mp
-80 °C (lit.)
密度
0.999 g/mL at 25 °C (lit.)
SMILES字符串
CCOCCOCCO
InChI
1S/C6H14O3/c1-2-8-5-6-9-4-3-7/h7H,2-6H2,1H3
InChI key
XXJWXESWEXIICW-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
法律信息
CARBITOL is a trademark of The Dow Chemical Company or an affiliated company of Dow
Vetec is a trademark of Merck KGaA, Darmstadt, Germany
储存分类代码
10 - Combustible liquids
WGK
WGK 1
闪点(°F)
204.8 °F - closed cup
闪点(°C)
96 °C - closed cup
Simona Mura et al.
Journal of drug targeting, 19(3), 189-196 (2010-05-08)
The aim of this work was to evaluate the ability of Transcutol (Trc) to produce elastic vesicles with soy lecithin (SL) and study the influence of the obtained vesicles on in vitro (trans)dermal delivery of minoxidil. To this purpose, so-called
Hyun-Jong Cho et al.
International journal of pharmaceutics, 423(2), 153-160 (2012-01-03)
To achieve rapid onset of action and improved bioavailability of udenafil, a microemulsion system was developed for its intranasal delivery. Phase behavior, particle size, transmission electron microscope (TEM) images, and the drug solubilization capacity of the microemulsion were investigated. A
Liandong Hu et al.
International journal of pharmaceutics, 420(2), 251-255 (2011-09-13)
The objective of the present study was to formulate a microemulsion system for oral administration to improve the solubility and bioavailability of fenofibrate. Various formulations were prepared using different ratios of oils, surfactants and co-surfactants (S&CoS). Pseudo-ternary phase diagrams were
Yousef Javadzadeh et al.
Colloids and surfaces. B, Biointerfaces, 82(2), 422-426 (2010-10-19)
Regarding the potential severe toxicity associated with systemic administration of methotrexate (MTX), a topical formulation might be of greater utility for the treatment of psoriasis and other hyperproliferative skin disorders. One of the presumed reasons for the lack of clinical
Roberta Censi et al.
Drug development and industrial pharmacy, 38(9), 1128-1133 (2011-12-23)
A microemulsion for the cutaneous release of quercetin was prepared. An aqueous phase, containing 40% Transcutol® P as solubilizing agent and permeation enhancer, was emulsified with Labrafil® as oil phase and Labrasol®/Capryol™ 90 as Solvent/Co-solvent. Quercetin was dissolved in the
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门